Martins · Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia 2026 · systematic review and meta-analysis of observational studies · n=13 studies

Association between High AMH Levels in PCOS Patients and IVF/ICSI Outcomes: a systematic review and meta-analysis.

Cited 0 times in the scientific literature.

Level 3 - non-randomized controlled study

Systematic review and meta-analysis of observational studies

PubMed 42500182 · doi:10.61622/rbgo/2026rbgo25 · record verified 2026-08-26

What was done

A systematic review and meta-analysis searched MEDLINE, Web of Science, and Scopus through September 17, 2024. The authors included observational studies of PCOS patients stratified by Anti-Müllerian Hormone (AMH) levels reporting IVF/ICSI outcomes (live birth rate, clinical pregnancy rate, miscarriage rate, oocytes retrieved, MII oocytes, and fertilization rate). Risk of bias was evaluated using the NHLBI Study Quality Assessment Tool, and sensitivity analyses were performed using a leave-one-out approach.

What was found

Across 13 included studies (10 low risk of bias, 2 unclear, 1 high risk): - Live birth rate was lower in women with high AMH levels (OR: 0.85; 95% CI: 0.71–1.02), which reached statistical significance in a leave-one-out sensitivity analysis (OR: 0.80; 95% CI: 0.64–0.99). - Oocytes retrieved were higher in the high AMH group (mean difference: 3.52; 95% CI: 1.70–5.33). - Clinical pregnancy rate showed no significant difference (OR: 0.98; 95% CI: 0.82–1.17). - Miscarriage rate showed a non-significant elevation (OR: 1.25; 95% CI: 0.88–1.76). - Fertilization rate showed no significant difference.

Why it matters

Although higher AMH indicates greater ovarian reserve and yields more retrieved oocytes, elevated AMH in PCOS patients may paradoxically compromise live birth success during IVF/ICSI.

Limits

The synthesis is restricted to observational studies subject to potential residual confounding. The abstract does not report the total participant count or the threshold values used to define high AMH across included studies. Differences in clinical protocols (stimulation type, fresh vs. frozen embryo transfer) across included studies were not described in the abstract.

Cited by